Zepbound Beats Wegovy, But Will Prices Drop?

So, Eli Lilly’s new weight loss shot, Zepbound, just outperformed Wegovy in a major trial—folks lost more pounds and inches on average. But before you rush to ask your doctor, here’s the twist: chatter online is all about whether Trump’s push to slash drug prices will actually make these meds affordable. Investors are nervous, but for everyday people, the real question is—will this new super-shot finally fit our budgets? Stay tuned! #WeightLoss #HealthNews #MoneyHacks #DrugPrices #Investing #Business